[Effects of the chronic administration of triazolam 0.50 mg on the sleep of insomniacs].
Several studies have been conducted in view to evaluate the short and medium-term efficacy of triazolam. The present investigation was aimed at assessing its long-term effectiveness. Four female and six male (average age: 29.9 years +/- 9.6) insomniacs took part in this study. After selection of the subjects, they are kept under observation in the sleep laboratory during two consecutive nights per week for ten weeks, during which they were given a placebo on weeks 1, 8, 9 and 10 and triazolam 0.50 mg on weeks 2 to 7. Triazolam proved to be an effective hypnotic during the six weeks of treatment, with no withdrawal effects upon discontinuation.
D000328:Adult; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012890:Sleep / Q000187:drug effects; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D013997:Time Factors; D014229:Triazolam / Q000008:administration & dosage / Q000627:therapeutic use*
D014151:Anti-Anxiety Agents; D014229:Triazolam
Effets de l'administration chronique de triazolam 0,50 mg sur le sommeil des insomniaques.